The global Fluoroscopy Systems Market size was valued at USD 2.2 billion in 2025 and is projected to grow from USD 2.3 billion in 2026 to USD 2.9 billion by 2033, at a CAGR of 3.4% from 2026 to 2033. North America dominated the market with the largest revenue share of 42.1% in 2025. Market growth is primarily driven by the rising geriatric population, increasing prevalence of chronic...

The global Interventional Cardiology Devices Market size was valued at USD 11.3 billion in 2025 and is projected to grow from USD 12.1 billion in 2026 to USD 19.8 billion by 2033, registering a CAGR of 7.3% from 2026 to 2033. North America dominated the global market with the largest revenue share of 46.1% in 2025, driven by the rising prevalence of cardiovascular diseases (CVDs),...

The absorbable cardiac stent market is witnessing strong growth as healthcare providers increasingly adopt innovative cardiovascular technologies that improve long-term patient outcomes. Unlike conventional metallic stents, absorbable cardiac stents provide temporary vessel support before gradually dissolving within the body, reducing the long-term risks associated with permanent implants....

7 clinical breakthroughs in bioresorbable polymers defining 2026 cardiology As we navigate the first quarter of 2026, the global interventional cardiology landscape is undergoing a tectonic shift toward transient scaffolding. Recent data from the European Society of Cardiology highlights a significant preference for magnesium-based alloys over traditional permanent metallic frames in younger...

Executive Summary As of early 2026, the Bioresorbable Scaffolds (BRS) Market is entering a period of renewed growth, characterized by "second-generation" thin-strut designs. Unlike traditional permanent metallic stents, BRS are designed to provide temporary mechanical support to an artery and then gradually resorb into the body. This "leave-nothing-behind" philosophy aims to restore the natural...

According to the latest report published by Data Bridge Market Research, the Robot Assisted Percutaneous Coronary Intervention (PCI) Market  CAGR Value The global robot assisted percutaneous coronary intervention (PCI) market size was valued at USD 18.33 billion in 2024 and is expected to reach USD 224.84 billion by 2032, at a CAGR of 36.80% during the forecast period In this...

The cardiac resynchronization therapy devices market is witnessing steady growth due to the increasing prevalence of heart failure, rising demand for advanced cardiac care solutions, and continuous innovations in implantable medical technologies. Cardiac resynchronization therapy devices are designed to improve heart function by coordinating ventricular contractions and enhancing cardiac...

The Digital Subtraction Angiography Equipment Market is witnessing significant expansion due to the increasing prevalence of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions worldwide. Digital subtraction angiography (DSA) has become one of the most effective imaging technologies for visualizing blood vessels with exceptional clarity by removing...

The drug eluting cardiovascular devices market is witnessing steady expansion as healthcare providers increasingly adopt advanced cardiovascular technologies to improve treatment outcomes for patients with coronary artery disease and other vascular disorders. These devices combine innovative drug delivery with medical device technology to reduce restenosis, enhance long-term vessel patency, and...

The dyslipidemia drugs market is experiencing steady growth as the global burden of cardiovascular diseases continues to rise. Dyslipidemia, characterized by abnormal cholesterol and lipid levels, is one of the leading risk factors for heart disease and stroke. Increasing awareness of preventive healthcare, improvements in lipid-lowering therapies, and growing emphasis on early disease...